The ultimate goal is to move forward how eye diseases are treated in the clinical setting with the ability to quickly detect the disease causing mutation, screen all family members, predict who will ...

The global artificial cornea and corneal implant market size was US$ 381.5 million in 2021. The global artificial cornea and corneal implant market is forecast to grow to US$ 701.4 million by 2030 by ...

or corneal abnormalities. "Aniridia means 'lack of iris,' but it is actually a disease that affects multiple parts of the eye," explains M. Carmen Acosta, a professor at UMH and a researcher in ...

Approximately 4% of people aged 40 years and older have corneal endothelial disease/dystrophy (CED ... (injection into the anterior chamber of the eye) of its engineered form of FGF1 in patients ...

The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028. A corneal ...

Cyclosporine 0.09% significantly improves CFS scores and tear production in patients with uncontrolled dry eye disease ... significant improvements in corneal staining and tear production ...

“Alcon is dedicated to developing and delivering innovative treatments for global unmet needs in eye care, including vision-threatening corneal endothelial disease, which affects millions of ...

Quirónsalud Marbella Hospital has become one of the few medical centres in Spain to perform Descemet Membrane Endothelial ...

Her laboratory is responsible for identification of genes for many different diseases, most recently for Age-Related Macular Degeneration (AMD) and Fuchs’ Endothelial Corneal Dystrophy (FECD). Her ...